SEC Form 4 · accession 0000899243-19-004393
TCR2 THERAPEUTICS INC. · TCRR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Neil W Gibson
Director
Period of report
Feb 19, 2019
Accepted (ET)
Feb 21, 2019 · 4:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001750019
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Feb 19, 2019 | C | 706,351 | — | A | 706,351 | I | See Footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series B Preferred StockF1,F2 | — | Feb 19, 2019 | C | 4,375,000 | D | — | — | Common Stock | 706,351 | 0 | I |
Explanation of responses
- F1Each share of Series B Preferred Stock converted into shares of the Issuer's common stock, par value $0.0001 ("Common Stock"), on a 6.1938:1 basis upon the closing of the Issuer's initial public offering.
- F2The shares are held by Curative Ventures CT LLC. The Reporting Person is a partner at Curative Ventures CT LLC and disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein, if any.